There’s no better state in the union than Utah for competitive growth in the life sciences industry. When BioFire Diagnostics, Inc., a clinical diagnostics company that develops and manufactures high-quality instruments for pathogen identification and DNA analysis, recently made the decision to expand its operations, the Governor’s Office of Economic Development (GOED) stepped up to support the expansion with an Economic Development Tax Increment Financing (EDTIF) post-performance refundable tax credit estimated to be worth approximately $25 million. For Utah, this expansion will mean up to 657 new high-paying jobs in the research and diagnostics sector and up to $50 million of capital investment in the nation’s most resilient economy.
